You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fibroblast growth factor (FGF)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibroblast Growth Factor 21, Tast Perference Trial (Fibroblast growth factor 21 infusion, Placebo infusion (saline))

Active, not recruiting
  • Fibroblast Growth Factor 21
  • Tast Perference
  • Fibroblast growth factor 21 infusion
  • Placebo infusion (saline)
  • Hellerup, Denmark
    Amalie R Lanng
Nov 21, 2022

NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)

Completed
  • NAFLD
  • Soy isoflavone
  • Placebo
  • Ahvaz, Khuzestan, Iran, Islamic Republic of
    Asal Neshatbini Tehrani
Oct 24, 2023

Healthy Trial in Frederiksberg (Sucrose, Sucrose + protein, Sucrose + fat)

Completed
  • Healthy
  • Sucrose
  • +2 more
  • Frederiksberg, Denmark
    Department of Nutrition, Exercise and Sports, University of Cope
Mar 30, 2022

Gestational Diabetes Trial in ChiangMai (blood draw)

Active, not recruiting
  • Gestational Diabetes
  • blood draw
  • ChiangMai, Thailand
    Maharaj Nakorn ChiangMai Hospital
Dec 1, 2022

Fasting Trial in Boston (oral carbohydrate challenge)

Active, not recruiting
  • Fasting
  • oral carbohydrate challenge
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Jul 18, 2022

Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba

Active, not recruiting
  • Fibroblast Growth Factor 23
  • +2 more
    • Córdoba, Spain
      Hospital Universitario Reina Sofia
    Apr 27, 2022

    Tympanic Membrane Perforation Trial in Boston, Lackland Air Force Base (FGF-2, Placebo)

    Completed
    Has Results
    • Tympanic Membrane Perforation
    • Boston, Massachusetts
    • +1 more
    Dec 7, 2020

    Serum Fibroblast Growth Factor-21 Levels During Prolonged

    Completed
    • Fibroblast Growth Factor-21
    • Fasting
    • 12 hour fasting for 29 days
    • Ankara, Turkey
      Hacettepe University Nutrition and Dietetics Department
    Mar 29, 2023

    FGF23 as a Marker of Acute Kidney Injury

    Recruiting
    • Acute Kidney Injury
    • Kidney Ischemia
    • Plasmatic Fibroblast Growth Factor-23 by means of ELISA
    • Santiago, Chile
      Hospital Clinic Universidad de Chile
    Dec 30, 2020

    Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)

    Not yet recruiting
    • Fibrous Dysplasia Of Bone
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Fibroblast Growth Factor 23 and Sclerostin in Relation to

    Not yet recruiting
    • COVID-19
    • Calcium
    • +3 more
    • Aswan, Egypt
      Aswan University hospital
    Mar 11, 2022

    Fibroblast Growth Factor 23 in Chronic Respiratory Failure

    Not yet recruiting
    • Chronic Respiratory Failure
    • Dosage
    • Cardiac echography
    • (no location specified)
    Feb 17, 2022

    Healthy, Chronic Kidney Disease Trial in Birmingham (Diet)

    Completed
    • Healthy
    • Chronic Kidney Disease
    • Diet
    • Birmingham, Alabama
      University of Alabama
    Mar 10, 2021

    Periodontitis Trial in Hyderabad (FGF 2)

    Completed
    • Periodontitis
    • FGF 2
    • Hyderabad, Andhra Pradesh, India
      SVS Institute of Dental Sciences, Mahabubnagar
    Apr 29, 2020

    Selected Factors on Cardiovascular System in Chronic Kidney

    Completed
    • Atherosclerosis of Artery
    • +4 more
    • laboratory parameters - complete blood count
    • +23 more
    • Poznań, Poland
      Poznan University of Medical Sciences
    Jan 25, 2022

    Fibroblast Growth Factor 23 and Hypertensive Disorder

    Recruiting
    • Hypertension, Pregnancy-Induced
      • Guangzhou, Guangdong, China
        Obstetrics and Gynechology Department of the 1st affiliated hosp
      Sep 5, 2021

      Tumor Trial in China, Korea, Republic of, Taiwan (Erdafitinib)

      Active, not recruiting
      • Neoplasm
      • Beijing, China
      • +5 more
      Jan 31, 2023

      Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)

      Withdrawn
      • Bladder Transitional Cell Carcinoma
      • +2 more
      • (no location specified)
      Aug 8, 2022

      Coronary Disease, Coronary Heart Disease, Myocardial Ischemia Trial (Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) -

      Not yet recruiting
      • Coronary Disease
      • +3 more
      • Human Recombinant Fibroblast Growth Factor-1 (FGF 1-141) - low dose
      • +2 more
      • (no location specified)
      Oct 31, 2019

      Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in

      Recruiting
      • Locally Advanced Gastrointestinal Stromal Tumor
      • +7 more
      • Biopsy
      • +4 more
      • Duarte, California
      • +17 more
      Feb 2, 2023

      Markers of Metabolism and Vascular Access in ESRD

      Not yet recruiting
      • Disorders of Calcium and Bone Metabolism
      • vascular acess
      • (no location specified)
      May 2, 2023

      Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

      Recruiting
      • Urothelial Carcinoma
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Mar 8, 2023

      Chronic Kidney Disease Trial in Montpellier, Saint-Jean-de-Védas (Plasma osteoprotegerin level, Plasma fibroblast growth factor

      Recruiting
      • Chronic Kidney Disease
      • Plasma osteoprotegerin level
      • +2 more
      • Montpellier, France
      • +6 more
      Dec 31, 2021

      Intermittent Claudication, Peripheral Arterial Disease Trial in Matsuyama, Fukuoka, Osaka (DVC1-0101)

      Active, not recruiting
      • Intermittent Claudication
      • Peripheral Arterial Disease
      • Matsuyama, Ehime, Japan
      • +3 more
      Aug 16, 2022

      Nonalcoholic Steatohepatitis Trial in Glendale (B1344, Placebo)

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Glendale, California
        California Clinical Trials Medical Group, Inc.
      Dec 8, 2022